Seven factors – longer diabetes duration, older age, overweight/obesity, diabetes treatment modalities (oral antidiabetic drugs [OADs] and/or insulin), female gender, medication non-adherence, and the presence of dyslipidaemia – were reported by ≥10% of the studies (Figure 5). This evidence concerns the gene INS and obesity disorder.